Depo-Provera MDL 3140: the July 27 conference is a reminder not to wait on records
A practical update on Depo-Provera MDL 3140, the July 27 conference, Rule 702 schedule, and records potential meningioma claimants should gather now.
-
-
Depo-Provera MDL 3140 Update: Settlement Talk Does Not End the Work for Meningioma Claimants
A July 2026 plain-English update on Depo-Provera meningioma lawsuits, the federal MDL, settlement-in-principle reports, label history, and records potential claimants should save now.
-
Depo-Provera MDL 3140 July 2026 update: case growth, expert hearing, and what claimants should save
A plain-English July 2026 update on Depo-Provera MDL 3140, including the case count, Rule 702 hearing, bellwether timeline, and records potential claimants should preserve.
-
Depo-Provera MDL 3140 update: settlement talks, Daubert hearing, and meningioma claims
A July 2026 update on Depo-Provera MDL 3140, including the June settlement-development order, the July 27 Rule 702 hearing, case counts, and records potential claimants should gather.
-
Depo-Provera MDL update: the July 2026 numbers families should know
A July 2026 update on Depo-Provera meningioma claims, MDL 3140 case counts, the Rule 702 schedule, FDA label warnings, and what families should collect before a legal review.
-
Depo-Provera MDL update: what the June rulings mean for meningioma claims
A plain-English July 2026 update on Depo-Provera meningioma claims, MDL 3140 court activity, and records potential claimants should gather.
-
Depo-Provera MDL 3140: the July count is up, and records matter now
The July 2026 JPML report lists 5,830 pending Depo-Provera MDL actions. Here is what women with meningioma should know about records, warnings, and claim review.
